08.08 07:02 | Kuros Biosciences Reports First Half of 2024 Results |
08.08 07:02 | Kuros Biosciences Reports First Half of 2024 -2- |
08.08 07:01 | dpa-AFX: EQS-Adhoc: Kuros Biosciences Reports First Half of 2024 Results (english) |
08.08 07:01 | Kuros Biosciences Reports First Half of 2024 Results |
08.08 07:01 | Kuros Biosciences Reports First Half of 2024 -2- |
25.06 07:00 | Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft |
25.06 07:00 | dpa-AFX: EQS-News: Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft (english) |
24.04 07:00 | Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales |
24.04 07:00 | dpa-AFX: EQS-Adhoc: Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales (english) |
17.04 14:05 | Annual General Meeting of Kuros Biosciences approves all resolutions |
17.04 14:05 | dpa-AFX: EQS-News: Annual General Meeting of Kuros Biosciences approves all resolutions (english) |
13.03 07:00 | dpa-AFX: EQS-Adhoc: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 (english) |
13.03 07:00 | Kuros reports 163% growth in direct MagnetOs -2- |
13.03 07:00 | Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 |
08.03 07:00 | dpa-AFX: EQS-News: Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update (english) |
08.03 07:00 | Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update |
01.02 07:00 | Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference |
01.02 07:00 | dpa-AFX: EQS-News: Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference (english) |
31.01 07:00 | dpa-AFX: EQS-News: Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand (english) |
31.01 07:00 | Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand |
|